A one-stop service encompassing all necessary steps, from processing complex time-series multi-omics data (RNA-seq, ATAC-seq) to delivering a final, prioritized Actionable Therapeutic Target Report.
Creative Biolabs provides a critical advancement in longevity research by delivering predictive causality. We move beyond static gene expression profiling to accurately quantify the dynamic activity of master transcription factors (TFs) like FOXO and Nrf2 using time-series multi-omic data and advanced GRN modeling. Clients can expect to gain a concise, highly prioritized list of rate-limiting therapeutic targets. This results in accelerated target validation, a significant reduction in screening costs, and higher confidence in developing interventions that modulate the core regulatory architecture of aging.
Aging is driven by dynamic changes in TF activity, not merely gene expression. Our service addresses the "critical flaw" of static data by modeling the longevity GRN as a dynamical system. This approach, validated by studies using ordinary differential equations (ODEs) and Waddington's epigenetic landscape, proves that controlling TF dynamics (e.g., p53) can shift cell fate from an aged/senescent attractor toward a youthful/homeostasis attractor. We provide predictive, mechanism-based insights for therapeutic intervention and target validation.
Initiate project scoping and request a formal consultation.
Fig.1 Outside-in and inside-out interplay of longevity pathways and extracellular matrix components. 1
A one-stop service encompassing all necessary steps, from processing complex time-series multi-omics data (RNA-seq, ATAC-seq) to delivering a final, prioritized Actionable Therapeutic Target Report.
We employ proprietary algorithms rooted in ODEs and dynamic systems theory to guarantee the stability and causality of the identified regulatory networks, exceeding standard correlational approaches.
Our process ensures the stability of regulatory information by quantifying true, transient TF activity dynamics (e.g., nuclear translocation kinetics), providing data quality and depth unmatched by bulk sequencing alone.
We optimize your target discovery process by mathematically identifying the rate-limiting hub TFs - the master switches of the aging network - allowing you to focus resources on the highest-impact targets first.
| Output Feature | Unique Advantage |
|---|---|
| Dynamic Activity vs. Expression | We quantify true TF activity (e.g., DAF-16/FOXO phosphorylation and nuclear translocation), not just constant mRNA levels, addressing the "Hit-and-Run" problem. |
| Cellular Fate Prediction | Our use of ODE-based dynamic GRN models allows us to map cellular states as attractors (Homeostasis, Senescence, Cancer), enabling us to predict the effect of perturbations on cell fate. |
| Cofactor and Complex Inference | By analyzing in vivo motif discovery and chromatin accessibility data, we infer the presence of regulatory cofactors, identifying high-value co-regulatory TF complexes for targeted intervention. |
| Single-Cell Resolution | We incorporate single-cell data into our network models, accounting for cellular heterogeneity that is often masked in bulk sequencing. |
To fully leverage the insights generated by our dynamic TF activity analysis in longevity GRN, we invite you to get a quote today.
We integrate single-cell resolution data where available into our network models. This is crucial because aging is often asynchronous across cell types. By modeling the GRN in a cell-type-specific manner, we ensure that the identified regulatory dynamics and rate-limiting TFs are relevant to the specific cell population you intend to target.
Standard methods provide static snapshots (what is expressed or bound), while our service delivers predictive causality (what drives the change). We prioritize targets that are validated to be "hub TFs" controlling the entire network, reducing the validation bottleneck that results from thousands of non-causal differentially expressed genes.
We track the time-resolved phosphorylation and activity of crucial kinase nodes within the GRN. This reveals the immediate upstream signaling triggers that directly control TF dynamics, helping you identify highly druggable targets before transcriptional events.
Learn More →We quantify time-resolved metabolic shifts (e.g., glycolysis, redox state) to link regulatory changes to the cell's energetic status. This provides a powerful, functional validation layer for longevity interventions by confirming the impact of TF and Kinase dynamics.
Learn More →Creative Biolabs provides the critical shift from static observation to predictive, dynamic causality in aging research. By focusing on the transient activity and complex regulatory architecture of master TFs like FOXO, Nrf2, and p53, we offer the most precise and actionable therapeutic targets available. Contact our team to discuss your project and discover how we can transform your longevity pipeline today.
Reference